nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—SLC22A2—Cladribine—multiple sclerosis	0.134	0.186	CbGbCtD
Flurazepam—CYP2E1—Fingolimod—multiple sclerosis	0.109	0.152	CbGbCtD
Flurazepam—CYP2A6—Prednisolone—multiple sclerosis	0.0683	0.0953	CbGbCtD
Flurazepam—CYP2E1—Mitoxantrone—multiple sclerosis	0.0513	0.0715	CbGbCtD
Flurazepam—CYP2A6—Dexamethasone—multiple sclerosis	0.0403	0.0562	CbGbCtD
Flurazepam—ABCB1—Methylprednisolone—multiple sclerosis	0.0355	0.0496	CbGbCtD
Flurazepam—CYP3A4—Fingolimod—multiple sclerosis	0.033	0.0461	CbGbCtD
Flurazepam—CYP2E1—Dexamethasone—multiple sclerosis	0.0266	0.0371	CbGbCtD
Flurazepam—ABCB1—Mitoxantrone—multiple sclerosis	0.0259	0.0362	CbGbCtD
Flurazepam—ABCB1—Betamethasone—multiple sclerosis	0.0231	0.0322	CbGbCtD
Flurazepam—ABCB1—Prednisolone—multiple sclerosis	0.0228	0.0318	CbGbCtD
Flurazepam—ABCB1—Prednisone—multiple sclerosis	0.0215	0.03	CbGbCtD
Flurazepam—CYP3A4—Methylprednisolone—multiple sclerosis	0.0213	0.0297	CbGbCtD
Flurazepam—CYP3A4—Triamcinolone—multiple sclerosis	0.0161	0.0225	CbGbCtD
Flurazepam—CYP3A4—Mitoxantrone—multiple sclerosis	0.0155	0.0217	CbGbCtD
Flurazepam—CYP3A4—Betamethasone—multiple sclerosis	0.0138	0.0193	CbGbCtD
Flurazepam—CYP3A4—Prednisolone—multiple sclerosis	0.0137	0.0191	CbGbCtD
Flurazepam—ABCB1—Dexamethasone—multiple sclerosis	0.0134	0.0188	CbGbCtD
Flurazepam—CYP3A4—Prednisone—multiple sclerosis	0.0129	0.018	CbGbCtD
Flurazepam—ABCB1—Methotrexate—multiple sclerosis	0.0108	0.0151	CbGbCtD
Flurazepam—GABRR3—peripheral nervous system—multiple sclerosis	0.00933	0.0601	CbGeAlD
Flurazepam—GABRR2—peripheral nervous system—multiple sclerosis	0.00809	0.0521	CbGeAlD
Flurazepam—CYP3A4—Dexamethasone—multiple sclerosis	0.00806	0.0112	CbGbCtD
Flurazepam—GABRR1—peripheral nervous system—multiple sclerosis	0.00779	0.0501	CbGeAlD
Flurazepam—GABRQ—nerve—multiple sclerosis	0.00728	0.0468	CbGeAlD
Flurazepam—GABRR3—nerve—multiple sclerosis	0.00728	0.0468	CbGeAlD
Flurazepam—GABRR2—nerve—multiple sclerosis	0.00631	0.0406	CbGeAlD
Flurazepam—GABRR1—nerve—multiple sclerosis	0.00607	0.0391	CbGeAlD
Flurazepam—GABRR3—retina—multiple sclerosis	0.00301	0.0194	CbGeAlD
Flurazepam—GABRR2—retina—multiple sclerosis	0.00261	0.0168	CbGeAlD
Flurazepam—GABRR1—retina—multiple sclerosis	0.00252	0.0162	CbGeAlD
Flurazepam—GABRA6—brainstem—multiple sclerosis	0.00217	0.014	CbGeAlD
Flurazepam—GABRQ—nervous system—multiple sclerosis	0.00164	0.0105	CbGeAlD
Flurazepam—GABRR3—nervous system—multiple sclerosis	0.00164	0.0105	CbGeAlD
Flurazepam—GABRB2—brainstem—multiple sclerosis	0.0016	0.0103	CbGeAlD
Flurazepam—GABRD—medulla oblongata—multiple sclerosis	0.00158	0.0102	CbGeAlD
Flurazepam—GABRQ—central nervous system—multiple sclerosis	0.00158	0.0101	CbGeAlD
Flurazepam—GABRG1—medulla oblongata—multiple sclerosis	0.00152	0.00979	CbGeAlD
Flurazepam—GABRB1—medulla oblongata—multiple sclerosis	0.00147	0.00949	CbGeAlD
Flurazepam—GABRA2—brainstem—multiple sclerosis	0.00146	0.00939	CbGeAlD
Flurazepam—GABRD—midbrain—multiple sclerosis	0.00144	0.00929	CbGeAlD
Flurazepam—GABRG3—nervous system—multiple sclerosis	0.00143	0.00923	CbGeAlD
Flurazepam—GABRR2—nervous system—multiple sclerosis	0.00142	0.00913	CbGeAlD
Flurazepam—GABRA1—brainstem—multiple sclerosis	0.00141	0.00907	CbGeAlD
Flurazepam—GABRG1—midbrain—multiple sclerosis	0.00139	0.00895	CbGeAlD
Flurazepam—GABRG3—central nervous system—multiple sclerosis	0.00138	0.00888	CbGeAlD
Flurazepam—GABRR1—nervous system—multiple sclerosis	0.00137	0.00879	CbGeAlD
Flurazepam—GABRG1—spinal cord—multiple sclerosis	0.00136	0.00873	CbGeAlD
Flurazepam—GABRB1—midbrain—multiple sclerosis	0.00135	0.00868	CbGeAlD
Flurazepam—GABRR2—cerebellum—multiple sclerosis	0.00134	0.0086	CbGeAlD
Flurazepam—GABRR1—central nervous system—multiple sclerosis	0.00132	0.00847	CbGeAlD
Flurazepam—GABRB1—spinal cord—multiple sclerosis	0.00131	0.00846	CbGeAlD
Flurazepam—GABRQ—brain—multiple sclerosis	0.00125	0.00805	CbGeAlD
Flurazepam—GABRD—nervous system—multiple sclerosis	0.00119	0.00764	CbGeAlD
Flurazepam—GABRD—central nervous system—multiple sclerosis	0.00114	0.00736	CbGeAlD
Flurazepam—GABRG1—nervous system—multiple sclerosis	0.00114	0.00736	CbGeAlD
Flurazepam—GABRA6—nervous system—multiple sclerosis	0.00114	0.00731	CbGeAlD
Flurazepam—GABRD—cerebellum—multiple sclerosis	0.00112	0.00719	CbGeAlD
Flurazepam—GABRB2—medulla oblongata—multiple sclerosis	0.00111	0.00716	CbGeAlD
Flurazepam—GABRG2—medulla oblongata—multiple sclerosis	0.00111	0.00716	CbGeAlD
Flurazepam—GABRB1—nervous system—multiple sclerosis	0.00111	0.00713	CbGeAlD
Flurazepam—GABRA5—nervous system—multiple sclerosis	0.0011	0.00709	CbGeAlD
Flurazepam—GABRG1—central nervous system—multiple sclerosis	0.0011	0.00708	CbGeAlD
Flurazepam—GABRG3—brain—multiple sclerosis	0.0011	0.00705	CbGeAlD
Flurazepam—GABRA6—central nervous system—multiple sclerosis	0.00109	0.00704	CbGeAlD
Flurazepam—GABRG1—cerebellum—multiple sclerosis	0.00108	0.00692	CbGeAlD
Flurazepam—GABRA6—cerebellum—multiple sclerosis	0.00107	0.00688	CbGeAlD
Flurazepam—GABRB1—central nervous system—multiple sclerosis	0.00107	0.00687	CbGeAlD
Flurazepam—GABRA5—central nervous system—multiple sclerosis	0.00106	0.00683	CbGeAlD
Flurazepam—GABRR1—brain—multiple sclerosis	0.00104	0.00672	CbGeAlD
Flurazepam—GABRB1—cerebellum—multiple sclerosis	0.00104	0.00671	CbGeAlD
Flurazepam—GABRA3—nervous system—multiple sclerosis	0.00103	0.0066	CbGeAlD
Flurazepam—GABRB2—midbrain—multiple sclerosis	0.00102	0.00655	CbGeAlD
Flurazepam—GABRG2—midbrain—multiple sclerosis	0.00102	0.00655	CbGeAlD
Flurazepam—GABRA4—nervous system—multiple sclerosis	0.001	0.00644	CbGeAlD
Flurazepam—GABRB2—spinal cord—multiple sclerosis	0.000993	0.00639	CbGeAlD
Flurazepam—GABRG2—spinal cord—multiple sclerosis	0.000993	0.00639	CbGeAlD
Flurazepam—GABRA3—central nervous system—multiple sclerosis	0.000988	0.00636	CbGeAlD
Flurazepam—GABRA1—medulla oblongata—multiple sclerosis	0.000983	0.00633	CbGeAlD
Flurazepam—GABRA4—central nervous system—multiple sclerosis	0.000963	0.0062	CbGeAlD
Flurazepam—GABRA4—cerebellum—multiple sclerosis	0.000941	0.00606	CbGeAlD
Flurazepam—GABRD—brain—multiple sclerosis	0.000907	0.00584	CbGeAlD
Flurazepam—GABRA1—midbrain—multiple sclerosis	0.000898	0.00578	CbGeAlD
Flurazepam—GABRA1—spinal cord—multiple sclerosis	0.000876	0.00564	CbGeAlD
Flurazepam—GABRG1—brain—multiple sclerosis	0.000873	0.00562	CbGeAlD
Flurazepam—GABRA6—brain—multiple sclerosis	0.000868	0.00559	CbGeAlD
Flurazepam—GABRB3—medulla oblongata—multiple sclerosis	0.000855	0.0055	CbGeAlD
Flurazepam—GABRB1—brain—multiple sclerosis	0.000847	0.00545	CbGeAlD
Flurazepam—GABRA5—brain—multiple sclerosis	0.000842	0.00542	CbGeAlD
Flurazepam—GABRB2—nervous system—multiple sclerosis	0.000836	0.00538	CbGeAlD
Flurazepam—GABRG2—nervous system—multiple sclerosis	0.000836	0.00538	CbGeAlD
Flurazepam—CYP2A6—cerebellum—multiple sclerosis	0.000814	0.00524	CbGeAlD
Flurazepam—GABRB2—central nervous system—multiple sclerosis	0.000805	0.00518	CbGeAlD
Flurazepam—GABRG2—central nervous system—multiple sclerosis	0.000805	0.00518	CbGeAlD
Flurazepam—Agranulocytosis—Azathioprine—multiple sclerosis	0.000797	0.00721	CcSEcCtD
Flurazepam—GABRB2—cerebellum—multiple sclerosis	0.000787	0.00507	CbGeAlD
Flurazepam—GABRG2—cerebellum—multiple sclerosis	0.000787	0.00507	CbGeAlD
Flurazepam—GABRA3—brain—multiple sclerosis	0.000784	0.00505	CbGeAlD
Flurazepam—GABRB3—midbrain—multiple sclerosis	0.000781	0.00503	CbGeAlD
Flurazepam—Dizziness—Fingolimod—multiple sclerosis	0.000781	0.00707	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.000775	0.00701	CcSEcCtD
Flurazepam—GABRA4—brain—multiple sclerosis	0.000764	0.00492	CbGeAlD
Flurazepam—GABRA2—nervous system—multiple sclerosis	0.000764	0.00492	CbGeAlD
Flurazepam—GABRB3—spinal cord—multiple sclerosis	0.000762	0.00491	CbGeAlD
Flurazepam—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000759	0.00687	CcSEcCtD
Flurazepam—GABRE—nervous system—multiple sclerosis	0.000758	0.00488	CbGeAlD
Flurazepam—Headache—Fingolimod—multiple sclerosis	0.00074	0.0067	CcSEcCtD
Flurazepam—GABRA1—nervous system—multiple sclerosis	0.000738	0.00475	CbGeAlD
Flurazepam—GABRA2—central nervous system—multiple sclerosis	0.000736	0.00474	CbGeAlD
Flurazepam—GABRE—central nervous system—multiple sclerosis	0.000729	0.0047	CbGeAlD
Flurazepam—Euphoric mood—Dexamethasone—multiple sclerosis	0.000726	0.00656	CcSEcCtD
Flurazepam—Euphoric mood—Betamethasone—multiple sclerosis	0.000726	0.00656	CcSEcCtD
Flurazepam—GABRA2—cerebellum—multiple sclerosis	0.000719	0.00463	CbGeAlD
Flurazepam—GABRA1—central nervous system—multiple sclerosis	0.000711	0.00458	CbGeAlD
Flurazepam—Chest pain—Cladribine—multiple sclerosis	0.000698	0.00632	CcSEcCtD
Flurazepam—Arthralgia—Cladribine—multiple sclerosis	0.000698	0.00632	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000698	0.00632	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000696	0.0063	CcSEcCtD
Flurazepam—Anxiety—Cladribine—multiple sclerosis	0.000696	0.0063	CcSEcCtD
Flurazepam—GABRA1—cerebellum—multiple sclerosis	0.000695	0.00447	CbGeAlD
Flurazepam—Drowsiness—Mitoxantrone—multiple sclerosis	0.00069	0.00624	CcSEcCtD
Flurazepam—Confusional state—Cladribine—multiple sclerosis	0.000675	0.00611	CcSEcCtD
Flurazepam—Sweating—Mitoxantrone—multiple sclerosis	0.000662	0.00599	CcSEcCtD
Flurazepam—CYP2A6—brain—multiple sclerosis	0.000661	0.00425	CbGeAlD
Flurazepam—Chloroquine—TNF—multiple sclerosis	0.000656	0.517	CrCbGaD
Flurazepam—Dysarthria—Methotrexate—multiple sclerosis	0.00065	0.00588	CcSEcCtD
Flurazepam—Hyperhidrosis—Cladribine—multiple sclerosis	0.000647	0.00586	CcSEcCtD
Flurazepam—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000644	0.00583	CcSEcCtD
Flurazepam—Irritability—Methylprednisolone—multiple sclerosis	0.000643	0.00582	CcSEcCtD
Flurazepam—GABRB3—nervous system—multiple sclerosis	0.000642	0.00413	CbGeAlD
Flurazepam—Hyperkinesia—Prednisone—multiple sclerosis	0.000641	0.0058	CcSEcCtD
Flurazepam—GABRB2—brain—multiple sclerosis	0.000639	0.00411	CbGeAlD
Flurazepam—GABRG2—brain—multiple sclerosis	0.000639	0.00411	CbGeAlD
Flurazepam—Anorexia—Cladribine—multiple sclerosis	0.000638	0.00577	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000633	0.00573	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000633	0.00573	CcSEcCtD
Flurazepam—Euphoric mood—Prednisone—multiple sclerosis	0.000632	0.00572	CcSEcCtD
Flurazepam—Hypotension—Cladribine—multiple sclerosis	0.000626	0.00566	CcSEcCtD
Flurazepam—Lethargy—Betamethasone—multiple sclerosis	0.000626	0.00566	CcSEcCtD
Flurazepam—Lethargy—Dexamethasone—multiple sclerosis	0.000626	0.00566	CcSEcCtD
Flurazepam—GABRB3—central nervous system—multiple sclerosis	0.000618	0.00398	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00061	0.00552	CcSEcCtD
Flurazepam—GABRB3—cerebellum—multiple sclerosis	0.000604	0.00389	CbGeAlD
Flurazepam—Leukopenia—Azathioprine—multiple sclerosis	0.000597	0.0054	CcSEcCtD
Flurazepam—Dyspnoea—Cladribine—multiple sclerosis	0.000597	0.0054	CcSEcCtD
Flurazepam—Somnolence—Cladribine—multiple sclerosis	0.000595	0.00539	CcSEcCtD
Flurazepam—Irritability—Dexamethasone—multiple sclerosis	0.000585	0.00529	CcSEcCtD
Flurazepam—Irritability—Betamethasone—multiple sclerosis	0.000585	0.00529	CcSEcCtD
Flurazepam—GABRA2—brain—multiple sclerosis	0.000584	0.00376	CbGeAlD
Flurazepam—Decreased appetite—Cladribine—multiple sclerosis	0.000582	0.00527	CcSEcCtD
Flurazepam—GABRE—brain—multiple sclerosis	0.000579	0.00373	CbGeAlD
Flurazepam—Constipation—Cladribine—multiple sclerosis	0.000573	0.00518	CcSEcCtD
Flurazepam—Arthralgia—Azathioprine—multiple sclerosis	0.000568	0.00514	CcSEcCtD
Flurazepam—GABRA1—brain—multiple sclerosis	0.000564	0.00363	CbGeAlD
Flurazepam—Coma—Methotrexate—multiple sclerosis	0.000562	0.00508	CcSEcCtD
Flurazepam—Feeling abnormal—Cladribine—multiple sclerosis	0.000552	0.00499	CcSEcCtD
Flurazepam—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000548	0.00495	CcSEcCtD
Flurazepam—Lethargy—Prednisone—multiple sclerosis	0.000545	0.00493	CcSEcCtD
Flurazepam—CYP2E1—medulla oblongata—multiple sclerosis	0.000544	0.0035	CbGeAlD
Flurazepam—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000528	0.00478	CcSEcCtD
Flurazepam—Irritability—Prednisone—multiple sclerosis	0.00051	0.00461	CcSEcCtD
Flurazepam—Hypotension—Azathioprine—multiple sclerosis	0.000509	0.0046	CcSEcCtD
Flurazepam—Vision blurred—Mitoxantrone—multiple sclerosis	0.000508	0.0046	CcSEcCtD
Flurazepam—Sweating—Methylprednisolone—multiple sclerosis	0.000498	0.00451	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000496	0.00449	CcSEcCtD
Flurazepam—GABRB3—brain—multiple sclerosis	0.000491	0.00316	CbGeAlD
Flurazepam—CYP2E1—spinal cord—multiple sclerosis	0.000485	0.00312	CbGeAlD
Flurazepam—Leukopenia—Mitoxantrone—multiple sclerosis	0.000483	0.00437	CcSEcCtD
Flurazepam—Asthenia—Cladribine—multiple sclerosis	0.00048	0.00435	CcSEcCtD
Flurazepam—Pruritus—Cladribine—multiple sclerosis	0.000474	0.00429	CcSEcCtD
Flurazepam—Hallucination—Methylprednisolone—multiple sclerosis	0.000464	0.0042	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000461	0.00417	CcSEcCtD
Flurazepam—Arthralgia—Mitoxantrone—multiple sclerosis	0.000459	0.00415	CcSEcCtD
Flurazepam—Chest pain—Mitoxantrone—multiple sclerosis	0.000459	0.00415	CcSEcCtD
Flurazepam—Diarrhoea—Cladribine—multiple sclerosis	0.000458	0.00415	CcSEcCtD
Flurazepam—Anxiety—Mitoxantrone—multiple sclerosis	0.000458	0.00414	CcSEcCtD
Flurazepam—Lethargy—Methotrexate—multiple sclerosis	0.000455	0.00412	CcSEcCtD
Flurazepam—Feeling abnormal—Azathioprine—multiple sclerosis	0.000449	0.00406	CcSEcCtD
Flurazepam—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000445	0.00403	CcSEcCtD
Flurazepam—Confusional state—Mitoxantrone—multiple sclerosis	0.000444	0.00402	CcSEcCtD
Flurazepam—Dizziness—Cladribine—multiple sclerosis	0.000443	0.00401	CcSEcCtD
Flurazepam—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00044	0.00398	CcSEcCtD
Flurazepam—Shock—Mitoxantrone—multiple sclerosis	0.000433	0.00392	CcSEcCtD
Flurazepam—ABCB1—retina—multiple sclerosis	0.000429	0.00276	CbGeAlD
Flurazepam—Irritability—Methotrexate—multiple sclerosis	0.000426	0.00385	CcSEcCtD
Flurazepam—Vomiting—Cladribine—multiple sclerosis	0.000426	0.00385	CcSEcCtD
Flurazepam—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000425	0.00385	CcSEcCtD
Flurazepam—Rash—Cladribine—multiple sclerosis	0.000422	0.00382	CcSEcCtD
Flurazepam—Hallucination—Betamethasone—multiple sclerosis	0.000422	0.00382	CcSEcCtD
Flurazepam—Hallucination—Dexamethasone—multiple sclerosis	0.000422	0.00382	CcSEcCtD
Flurazepam—Dermatitis—Cladribine—multiple sclerosis	0.000422	0.00382	CcSEcCtD
Flurazepam—Anorexia—Mitoxantrone—multiple sclerosis	0.00042	0.0038	CcSEcCtD
Flurazepam—Ataxia—Methotrexate—multiple sclerosis	0.00042	0.0038	CcSEcCtD
Flurazepam—Headache—Cladribine—multiple sclerosis	0.000419	0.0038	CcSEcCtD
Flurazepam—Vision blurred—Prednisolone—multiple sclerosis	0.000417	0.00377	CcSEcCtD
Flurazepam—Hypotension—Mitoxantrone—multiple sclerosis	0.000411	0.00372	CcSEcCtD
Flurazepam—CYP2E1—nervous system—multiple sclerosis	0.000409	0.00263	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000401	0.00363	CcSEcCtD
Flurazepam—Dysgeusia—Triamcinolone—multiple sclerosis	0.000398	0.0036	CcSEcCtD
Flurazepam—Nausea—Cladribine—multiple sclerosis	0.000398	0.0036	CcSEcCtD
Flurazepam—Syncope—Prednisolone—multiple sclerosis	0.000397	0.00359	CcSEcCtD
Flurazepam—CYP2E1—central nervous system—multiple sclerosis	0.000393	0.00253	CbGeAlD
Flurazepam—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000392	0.00355	CcSEcCtD
Flurazepam—Somnolence—Mitoxantrone—multiple sclerosis	0.000391	0.00354	CcSEcCtD
Flurazepam—Loss of consciousness—Prednisolone—multiple sclerosis	0.000389	0.00352	CcSEcCtD
Flurazepam—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000387	0.00351	CcSEcCtD
Flurazepam—CYP2E1—cerebellum—multiple sclerosis	0.000385	0.00248	CbGeAlD
Flurazepam—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000383	0.00346	CcSEcCtD
Flurazepam—Constipation—Mitoxantrone—multiple sclerosis	0.000376	0.00341	CcSEcCtD
Flurazepam—Diarrhoea—Azathioprine—multiple sclerosis	0.000372	0.00337	CcSEcCtD
Flurazepam—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00037	0.00334	CcSEcCtD
Flurazepam—Hallucination—Prednisone—multiple sclerosis	0.000367	0.00332	CcSEcCtD
Flurazepam—Syncope—Triamcinolone—multiple sclerosis	0.000365	0.0033	CcSEcCtD
Flurazepam—Syncope—Methylprednisolone—multiple sclerosis	0.000364	0.00329	CcSEcCtD
Flurazepam—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000363	0.00328	CcSEcCtD
Flurazepam—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000361	0.00327	CcSEcCtD
Flurazepam—Dizziness—Azathioprine—multiple sclerosis	0.00036	0.00326	CcSEcCtD
Flurazepam—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00036	0.00326	CcSEcCtD
Flurazepam—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000358	0.00324	CcSEcCtD
Flurazepam—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000357	0.00323	CcSEcCtD
Flurazepam—Shock—Prednisolone—multiple sclerosis	0.000355	0.00321	CcSEcCtD
Flurazepam—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000349	0.00316	CcSEcCtD
Flurazepam—Vomiting—Azathioprine—multiple sclerosis	0.000346	0.00313	CcSEcCtD
Flurazepam—Arthralgia—Methylprednisolone—multiple sclerosis	0.000346	0.00313	CcSEcCtD
Flurazepam—Anxiety—Methylprednisolone—multiple sclerosis	0.000344	0.00312	CcSEcCtD
Flurazepam—Drowsiness—Methotrexate—multiple sclerosis	0.000344	0.00311	CcSEcCtD
Flurazepam—Rash—Azathioprine—multiple sclerosis	0.000343	0.00311	CcSEcCtD
Flurazepam—Dermatitis—Azathioprine—multiple sclerosis	0.000343	0.0031	CcSEcCtD
Flurazepam—Flushing—Prednisone—multiple sclerosis	0.000343	0.0031	CcSEcCtD
Flurazepam—Headache—Azathioprine—multiple sclerosis	0.000341	0.00309	CcSEcCtD
Flurazepam—Dry mouth—Triamcinolone—multiple sclerosis	0.000339	0.00307	CcSEcCtD
Flurazepam—Confusional state—Methylprednisolone—multiple sclerosis	0.000334	0.00302	CcSEcCtD
Flurazepam—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000332	0.003	CcSEcCtD
Flurazepam—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000331	0.003	CcSEcCtD
Flurazepam—Syncope—Dexamethasone—multiple sclerosis	0.000331	0.003	CcSEcCtD
Flurazepam—Syncope—Betamethasone—multiple sclerosis	0.000331	0.003	CcSEcCtD
Flurazepam—Sweating—Methotrexate—multiple sclerosis	0.00033	0.00298	CcSEcCtD
Flurazepam—CYP3A4—nervous system—multiple sclerosis	0.000329	0.00212	CbGeAlD
Flurazepam—Shock—Triamcinolone—multiple sclerosis	0.000327	0.00296	CcSEcCtD
Flurazepam—Shock—Methylprednisolone—multiple sclerosis	0.000326	0.00295	CcSEcCtD
Flurazepam—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000324	0.00294	CcSEcCtD
Flurazepam—Loss of consciousness—Betamethasone—multiple sclerosis	0.000324	0.00294	CcSEcCtD
Flurazepam—Nausea—Azathioprine—multiple sclerosis	0.000323	0.00293	CcSEcCtD
Flurazepam—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000321	0.0029	CcSEcCtD
Flurazepam—Agranulocytosis—Methotrexate—multiple sclerosis	0.000321	0.0029	CcSEcCtD
Flurazepam—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00032	0.0029	CcSEcCtD
Flurazepam—CYP3A4—central nervous system—multiple sclerosis	0.000317	0.00204	CbGeAlD
Flurazepam—Asthenia—Mitoxantrone—multiple sclerosis	0.000316	0.00286	CcSEcCtD
Flurazepam—Anxiety—Betamethasone—multiple sclerosis	0.000313	0.00283	CcSEcCtD
Flurazepam—Anxiety—Dexamethasone—multiple sclerosis	0.000313	0.00283	CcSEcCtD
Flurazepam—CYP2E1—brain—multiple sclerosis	0.000312	0.00201	CbGeAlD
Flurazepam—ABCB1—medulla oblongata—multiple sclerosis	0.00031	0.00199	CbGeAlD
Flurazepam—Hypotension—Methylprednisolone—multiple sclerosis	0.00031	0.0028	CcSEcCtD
Flurazepam—Vision blurred—Prednisone—multiple sclerosis	0.000303	0.00274	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000303	0.00274	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000302	0.00273	CcSEcCtD
Flurazepam—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000301	0.00273	CcSEcCtD
Flurazepam—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000301	0.00273	CcSEcCtD
Flurazepam—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000301	0.00272	CcSEcCtD
Flurazepam—Feeling abnormal—Prednisolone—multiple sclerosis	0.000298	0.00269	CcSEcCtD
Flurazepam—Shock—Betamethasone—multiple sclerosis	0.000296	0.00268	CcSEcCtD
Flurazepam—Shock—Dexamethasone—multiple sclerosis	0.000296	0.00268	CcSEcCtD
Flurazepam—Dyspnoea—Triamcinolone—multiple sclerosis	0.000296	0.00268	CcSEcCtD
Flurazepam—Agitation—Prednisone—multiple sclerosis	0.000295	0.00267	CcSEcCtD
Flurazepam—Dyspepsia—Triamcinolone—multiple sclerosis	0.000292	0.00264	CcSEcCtD
Flurazepam—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000292	0.00264	CcSEcCtD
Flurazepam—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000291	0.00264	CcSEcCtD
Flurazepam—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000291	0.00264	CcSEcCtD
Flurazepam—Syncope—Prednisone—multiple sclerosis	0.000288	0.00261	CcSEcCtD
Flurazepam—Anorexia—Betamethasone—multiple sclerosis	0.000287	0.0026	CcSEcCtD
Flurazepam—Anorexia—Dexamethasone—multiple sclerosis	0.000287	0.0026	CcSEcCtD
Flurazepam—ABCB1—midbrain—multiple sclerosis	0.000283	0.00182	CbGeAlD
Flurazepam—Loss of consciousness—Prednisone—multiple sclerosis	0.000283	0.00256	CcSEcCtD
Flurazepam—Hypotension—Betamethasone—multiple sclerosis	0.000282	0.00255	CcSEcCtD
Flurazepam—Hypotension—Dexamethasone—multiple sclerosis	0.000282	0.00255	CcSEcCtD
Flurazepam—Vomiting—Mitoxantrone—multiple sclerosis	0.00028	0.00253	CcSEcCtD
Flurazepam—Rash—Mitoxantrone—multiple sclerosis	0.000277	0.00251	CcSEcCtD
Flurazepam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000277	0.00251	CcSEcCtD
Flurazepam—ABCB1—spinal cord—multiple sclerosis	0.000276	0.00178	CbGeAlD
Flurazepam—Headache—Mitoxantrone—multiple sclerosis	0.000276	0.00249	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000274	0.00248	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000274	0.00248	CcSEcCtD
Flurazepam—Arthralgia—Prednisone—multiple sclerosis	0.000274	0.00248	CcSEcCtD
Flurazepam—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000274	0.00248	CcSEcCtD
Flurazepam—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000273	0.00247	CcSEcCtD
Flurazepam—Anxiety—Prednisone—multiple sclerosis	0.000273	0.00247	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000271	0.00245	CcSEcCtD
Flurazepam—Dyspepsia—Dexamethasone—multiple sclerosis	0.000265	0.0024	CcSEcCtD
Flurazepam—Dyspepsia—Betamethasone—multiple sclerosis	0.000265	0.0024	CcSEcCtD
Flurazepam—Dysgeusia—Methotrexate—multiple sclerosis	0.000263	0.00238	CcSEcCtD
Flurazepam—Anaphylactic shock—Prednisone—multiple sclerosis	0.000262	0.00237	CcSEcCtD
Flurazepam—Decreased appetite—Dexamethasone—multiple sclerosis	0.000262	0.00237	CcSEcCtD
Flurazepam—Decreased appetite—Betamethasone—multiple sclerosis	0.000262	0.00237	CcSEcCtD
Flurazepam—Nausea—Mitoxantrone—multiple sclerosis	0.000261	0.00237	CcSEcCtD
Flurazepam—Shock—Prednisone—multiple sclerosis	0.000258	0.00234	CcSEcCtD
Flurazepam—Hyperhidrosis—Prednisone—multiple sclerosis	0.000254	0.00229	CcSEcCtD
Flurazepam—Vision blurred—Methotrexate—multiple sclerosis	0.000253	0.00229	CcSEcCtD
Flurazepam—Anorexia—Prednisone—multiple sclerosis	0.00025	0.00226	CcSEcCtD
Flurazepam—Feeling abnormal—Betamethasone—multiple sclerosis	0.000248	0.00225	CcSEcCtD
Flurazepam—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000248	0.00225	CcSEcCtD
Flurazepam—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000246	0.00223	CcSEcCtD
Flurazepam—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000246	0.00223	CcSEcCtD
Flurazepam—Leukopenia—Methotrexate—multiple sclerosis	0.00024	0.00218	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000239	0.00216	CcSEcCtD
Flurazepam—Dizziness—Prednisolone—multiple sclerosis	0.000239	0.00216	CcSEcCtD
Flurazepam—Asthenia—Triamcinolone—multiple sclerosis	0.000238	0.00216	CcSEcCtD
Flurazepam—Asthenia—Methylprednisolone—multiple sclerosis	0.000238	0.00215	CcSEcCtD
Flurazepam—Pruritus—Triamcinolone—multiple sclerosis	0.000235	0.00213	CcSEcCtD
Flurazepam—Pruritus—Methylprednisolone—multiple sclerosis	0.000234	0.00212	CcSEcCtD
Flurazepam—ABCB1—nervous system—multiple sclerosis	0.000233	0.0015	CbGeAlD
Flurazepam—Dyspepsia—Prednisone—multiple sclerosis	0.000231	0.00209	CcSEcCtD
Flurazepam—Arthralgia—Methotrexate—multiple sclerosis	0.000229	0.00207	CcSEcCtD
Flurazepam—Chest pain—Methotrexate—multiple sclerosis	0.000229	0.00207	CcSEcCtD
Flurazepam—Decreased appetite—Prednisone—multiple sclerosis	0.000228	0.00206	CcSEcCtD
Flurazepam—Rash—Prednisolone—multiple sclerosis	0.000228	0.00206	CcSEcCtD
Flurazepam—Dermatitis—Prednisolone—multiple sclerosis	0.000227	0.00206	CcSEcCtD
Flurazepam—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000227	0.00205	CcSEcCtD
Flurazepam—Headache—Prednisolone—multiple sclerosis	0.000226	0.00205	CcSEcCtD
Flurazepam—Constipation—Prednisone—multiple sclerosis	0.000224	0.00203	CcSEcCtD
Flurazepam—ABCB1—central nervous system—multiple sclerosis	0.000224	0.00144	CbGeAlD
Flurazepam—Confusional state—Methotrexate—multiple sclerosis	0.000221	0.002	CcSEcCtD
Flurazepam—Dizziness—Triamcinolone—multiple sclerosis	0.00022	0.00199	CcSEcCtD
Flurazepam—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000219	0.00198	CcSEcCtD
Flurazepam—Dizziness—Methylprednisolone—multiple sclerosis	0.000219	0.00198	CcSEcCtD
Flurazepam—ABCB1—cerebellum—multiple sclerosis	0.000219	0.00141	CbGeAlD
Flurazepam—Feeling abnormal—Prednisone—multiple sclerosis	0.000216	0.00196	CcSEcCtD
Flurazepam—Asthenia—Dexamethasone—multiple sclerosis	0.000216	0.00196	CcSEcCtD
Flurazepam—Asthenia—Betamethasone—multiple sclerosis	0.000216	0.00196	CcSEcCtD
Flurazepam—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000215	0.00194	CcSEcCtD
Flurazepam—Nausea—Prednisolone—multiple sclerosis	0.000214	0.00194	CcSEcCtD
Flurazepam—Pruritus—Dexamethasone—multiple sclerosis	0.000213	0.00193	CcSEcCtD
Flurazepam—Pruritus—Betamethasone—multiple sclerosis	0.000213	0.00193	CcSEcCtD
Flurazepam—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000212	0.00192	CcSEcCtD
Flurazepam—Vomiting—Triamcinolone—multiple sclerosis	0.000211	0.00191	CcSEcCtD
Flurazepam—Vomiting—Methylprednisolone—multiple sclerosis	0.000211	0.00191	CcSEcCtD
Flurazepam—Rash—Triamcinolone—multiple sclerosis	0.000209	0.00189	CcSEcCtD
Flurazepam—Dermatitis—Triamcinolone—multiple sclerosis	0.000209	0.00189	CcSEcCtD
Flurazepam—Anorexia—Methotrexate—multiple sclerosis	0.000209	0.00189	CcSEcCtD
Flurazepam—Rash—Methylprednisolone—multiple sclerosis	0.000209	0.00189	CcSEcCtD
Flurazepam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000209	0.00189	CcSEcCtD
Flurazepam—Headache—Triamcinolone—multiple sclerosis	0.000208	0.00188	CcSEcCtD
Flurazepam—Headache—Methylprednisolone—multiple sclerosis	0.000208	0.00188	CcSEcCtD
Flurazepam—Diarrhoea—Dexamethasone—multiple sclerosis	0.000206	0.00187	CcSEcCtD
Flurazepam—Diarrhoea—Betamethasone—multiple sclerosis	0.000206	0.00187	CcSEcCtD
Flurazepam—Hypotension—Methotrexate—multiple sclerosis	0.000205	0.00185	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.0002	0.00181	CcSEcCtD
Flurazepam—Dizziness—Dexamethasone—multiple sclerosis	0.000199	0.0018	CcSEcCtD
Flurazepam—Dizziness—Betamethasone—multiple sclerosis	0.000199	0.0018	CcSEcCtD
Flurazepam—Nausea—Triamcinolone—multiple sclerosis	0.000197	0.00178	CcSEcCtD
Flurazepam—Nausea—Methylprednisolone—multiple sclerosis	0.000197	0.00178	CcSEcCtD
Flurazepam—Dyspnoea—Methotrexate—multiple sclerosis	0.000195	0.00177	CcSEcCtD
Flurazepam—Somnolence—Methotrexate—multiple sclerosis	0.000195	0.00176	CcSEcCtD
Flurazepam—Dyspepsia—Methotrexate—multiple sclerosis	0.000193	0.00175	CcSEcCtD
Flurazepam—Vomiting—Betamethasone—multiple sclerosis	0.000192	0.00173	CcSEcCtD
Flurazepam—Vomiting—Dexamethasone—multiple sclerosis	0.000192	0.00173	CcSEcCtD
Flurazepam—Decreased appetite—Methotrexate—multiple sclerosis	0.000191	0.00172	CcSEcCtD
Flurazepam—Rash—Dexamethasone—multiple sclerosis	0.00019	0.00172	CcSEcCtD
Flurazepam—Rash—Betamethasone—multiple sclerosis	0.00019	0.00172	CcSEcCtD
Flurazepam—Dermatitis—Dexamethasone—multiple sclerosis	0.00019	0.00172	CcSEcCtD
Flurazepam—Dermatitis—Betamethasone—multiple sclerosis	0.00019	0.00172	CcSEcCtD
Flurazepam—Headache—Dexamethasone—multiple sclerosis	0.000189	0.00171	CcSEcCtD
Flurazepam—Headache—Betamethasone—multiple sclerosis	0.000189	0.00171	CcSEcCtD
Flurazepam—Asthenia—Prednisone—multiple sclerosis	0.000188	0.0017	CcSEcCtD
Flurazepam—Pruritus—Prednisone—multiple sclerosis	0.000186	0.00168	CcSEcCtD
Flurazepam—Chlorpromazine—BCHE—multiple sclerosis	0.000185	0.146	CrCbGaD
Flurazepam—Feeling abnormal—Methotrexate—multiple sclerosis	0.000181	0.00163	CcSEcCtD
Flurazepam—Diarrhoea—Prednisone—multiple sclerosis	0.00018	0.00162	CcSEcCtD
Flurazepam—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000179	0.00162	CcSEcCtD
Flurazepam—Nausea—Dexamethasone—multiple sclerosis	0.000179	0.00162	CcSEcCtD
Flurazepam—Nausea—Betamethasone—multiple sclerosis	0.000179	0.00162	CcSEcCtD
Flurazepam—ABCB1—brain—multiple sclerosis	0.000178	0.00115	CbGeAlD
Flurazepam—Dizziness—Prednisone—multiple sclerosis	0.000174	0.00157	CcSEcCtD
Flurazepam—Vomiting—Prednisone—multiple sclerosis	0.000167	0.00151	CcSEcCtD
Flurazepam—Rash—Prednisone—multiple sclerosis	0.000165	0.0015	CcSEcCtD
Flurazepam—Dermatitis—Prednisone—multiple sclerosis	0.000165	0.0015	CcSEcCtD
Flurazepam—Headache—Prednisone—multiple sclerosis	0.000164	0.00149	CcSEcCtD
Flurazepam—Clonazepam—ALB—multiple sclerosis	0.000159	0.126	CrCbGaD
Flurazepam—Asthenia—Methotrexate—multiple sclerosis	0.000157	0.00142	CcSEcCtD
Flurazepam—Nausea—Prednisone—multiple sclerosis	0.000156	0.00141	CcSEcCtD
Flurazepam—Pruritus—Methotrexate—multiple sclerosis	0.000155	0.0014	CcSEcCtD
Flurazepam—Diarrhoea—Methotrexate—multiple sclerosis	0.00015	0.00136	CcSEcCtD
Flurazepam—Dizziness—Methotrexate—multiple sclerosis	0.000145	0.00131	CcSEcCtD
Flurazepam—Vomiting—Methotrexate—multiple sclerosis	0.000139	0.00126	CcSEcCtD
Flurazepam—Rash—Methotrexate—multiple sclerosis	0.000138	0.00125	CcSEcCtD
Flurazepam—Dermatitis—Methotrexate—multiple sclerosis	0.000138	0.00125	CcSEcCtD
Flurazepam—Headache—Methotrexate—multiple sclerosis	0.000137	0.00124	CcSEcCtD
Flurazepam—Nausea—Methotrexate—multiple sclerosis	0.00013	0.00118	CcSEcCtD
Flurazepam—Clomipramine—ALB—multiple sclerosis	0.00011	0.0872	CrCbGaD
Flurazepam—Diazepam—ALB—multiple sclerosis	8.16e-05	0.0644	CrCbGaD
Flurazepam—Chlorpromazine—ALB—multiple sclerosis	7.58e-05	0.0598	CrCbGaD
Flurazepam—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	5.71e-05	0.00356	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	5.68e-05	0.00354	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.59e-05	0.00348	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.52e-05	0.00344	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.52e-05	0.00344	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.52e-05	0.00344	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.52e-05	0.00344	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.49e-05	0.00342	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—BCHE—multiple sclerosis	5.48e-05	0.00341	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—BCHE—multiple sclerosis	5.48e-05	0.00341	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.42e-05	0.00338	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	5.18e-05	0.00323	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.04e-05	0.00314	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.96e-05	0.00309	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.9e-05	0.00305	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.81e-05	0.003	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.81e-05	0.003	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.73e-05	0.00295	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.73e-05	0.00294	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.7e-05	0.00293	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.65e-05	0.00289	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.62e-05	0.00288	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.61e-05	0.00287	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	4.6e-05	0.00286	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.57e-05	0.00285	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.54e-05	0.00283	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.53e-05	0.00282	CbGpPWpGaD
Flurazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.52e-05	0.00282	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—BCHE—multiple sclerosis	4.51e-05	0.00281	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	4.49e-05	0.0028	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.47e-05	0.00279	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—BCHE—multiple sclerosis	4.44e-05	0.00277	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD28—multiple sclerosis	4.37e-05	0.00272	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.36e-05	0.00272	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.36e-05	0.00272	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.23e-05	0.00264	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—BCHE—multiple sclerosis	4.2e-05	0.00262	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.18e-05	0.0026	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	4.18e-05	0.0026	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—BCHE—multiple sclerosis	4.15e-05	0.00259	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	4.14e-05	0.00258	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	4.08e-05	0.00254	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.04e-05	0.00252	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.03e-05	0.00251	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD40—multiple sclerosis	3.99e-05	0.00248	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	3.96e-05	0.00247	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	3.93e-05	0.00245	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.86e-05	0.0024	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.85e-05	0.0024	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.85e-05	0.0024	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.82e-05	0.00238	CbGpPWpGaD
Flurazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.8e-05	0.00237	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—BCHE—multiple sclerosis	3.8e-05	0.00237	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.71e-05	0.00231	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.7e-05	0.00231	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.7e-05	0.00231	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—BCHE—multiple sclerosis	3.69e-05	0.0023	CbGpPWpGaD
Flurazepam—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.66e-05	0.00228	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.65e-05	0.00227	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	3.64e-05	0.00227	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—BCHE—multiple sclerosis	3.62e-05	0.00226	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.59e-05	0.00224	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.59e-05	0.00224	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.58e-05	0.00223	CbGpPWpGaD
Flurazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.57e-05	0.00223	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.56e-05	0.00222	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—BCHE—multiple sclerosis	3.56e-05	0.00222	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.54e-05	0.0022	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—BCHE—multiple sclerosis	3.54e-05	0.0022	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.53e-05	0.0022	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.5e-05	0.00218	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—BCHE—multiple sclerosis	3.47e-05	0.00216	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	3.46e-05	0.00215	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.35e-05	0.00208	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.3e-05	0.00206	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	3.23e-05	0.00201	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.17e-05	0.00198	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.17e-05	0.00198	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.17e-05	0.00198	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.13e-05	0.00195	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.13e-05	0.00195	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.13e-05	0.00195	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD86—multiple sclerosis	3.11e-05	0.00194	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.06e-05	0.0019	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL10—multiple sclerosis	3.05e-05	0.0019	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	3.05e-05	0.0019	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—BCHE—multiple sclerosis	3.04e-05	0.00189	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.02e-05	0.00188	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL4—multiple sclerosis	2.97e-05	0.00185	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.96e-05	0.00184	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.94e-05	0.00183	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.92e-05	0.00182	CbGpPWpGaD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.91e-05	0.00181	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	2.91e-05	0.00181	CbGpPWpGaD
Flurazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.9e-05	0.0018	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.88e-05	0.0018	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.83e-05	0.00177	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.81e-05	0.00175	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.81e-05	0.00175	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—BCHE—multiple sclerosis	2.79e-05	0.00174	CbGpPWpGaD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.78e-05	0.00173	CbGpPWpGaD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.78e-05	0.00173	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.76e-05	0.00172	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—FAS—multiple sclerosis	2.74e-05	0.00171	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	2.72e-05	0.0017	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	2.69e-05	0.00168	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.67e-05	0.00166	CbGpPWpGaD
Flurazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	2.64e-05	0.00164	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.6e-05	0.00162	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.55e-05	0.00159	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.5e-05	0.00156	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.49e-05	0.00155	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.46e-05	0.00153	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.44e-05	0.00152	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.42e-05	0.00151	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.29e-05	0.00143	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SRM—multiple sclerosis	2.29e-05	0.00143	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.27e-05	0.00142	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.25e-05	0.0014	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.22e-05	0.00138	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.19e-05	0.00136	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.14e-05	0.00133	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.13e-05	0.00133	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.11e-05	0.00131	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SRM—multiple sclerosis	2.1e-05	0.00131	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.09e-05	0.0013	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.09e-05	0.0013	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.02e-05	0.00126	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.97e-05	0.00123	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.96e-05	0.00122	CbGpPWpGaD
Flurazepam—CYP2A6—Biological oxidations—POMC—multiple sclerosis	1.95e-05	0.00121	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	1.93e-05	0.0012	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.93e-05	0.0012	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.87e-05	0.00117	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.85e-05	0.00115	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.84e-05	0.00114	CbGpPWpGaD
Flurazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.83e-05	0.00114	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.81e-05	0.00113	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.8e-05	0.00112	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.79e-05	0.00112	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.76e-05	0.0011	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	1.75e-05	0.00109	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.72e-05	0.00107	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.69e-05	0.00106	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—MAPK1—multiple sclerosis	1.68e-05	0.00105	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SRM—multiple sclerosis	1.66e-05	0.00103	CbGpPWpGaD
Flurazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.66e-05	0.00103	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	1.61e-05	0.001	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	1.61e-05	0.001	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.6e-05	0.000999	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.6e-05	0.000998	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—MAPK1—multiple sclerosis	1.6e-05	0.000997	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—MAPK1—multiple sclerosis	1.6e-05	0.000997	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.6e-05	0.000994	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.58e-05	0.000986	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.58e-05	0.000984	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.54e-05	0.000959	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—POMC—multiple sclerosis	1.54e-05	0.000958	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.53e-05	0.000955	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.000922	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.000922	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPC5—multiple sclerosis	1.47e-05	0.000919	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.45e-05	0.000906	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.45e-05	0.000902	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.41e-05	0.000876	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.39e-05	0.000865	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.39e-05	0.000864	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.39e-05	0.000864	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.38e-05	0.000861	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.36e-05	0.000846	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPC5—multiple sclerosis	1.35e-05	0.000843	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.35e-05	0.000842	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.35e-05	0.00084	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.34e-05	0.000838	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.34e-05	0.000837	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.32e-05	0.000825	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—MAPK1—multiple sclerosis	1.32e-05	0.000821	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—MAPK1—multiple sclerosis	1.3e-05	0.000809	CbGpPWpGaD
Flurazepam—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	1.28e-05	0.000797	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SRM—multiple sclerosis	1.25e-05	0.000779	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.24e-05	0.000776	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—MAPK1—multiple sclerosis	1.23e-05	0.000765	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—RRM1—multiple sclerosis	1.22e-05	0.000761	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—MAPK1—multiple sclerosis	1.21e-05	0.000756	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.21e-05	0.000755	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	1.17e-05	0.000729	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	1.17e-05	0.000729	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.16e-05	0.000724	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.16e-05	0.000721	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.14e-05	0.000712	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.13e-05	0.000701	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000699	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—MAPK1—multiple sclerosis	1.11e-05	0.000691	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.09e-05	0.000676	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—MAPK1—multiple sclerosis	1.08e-05	0.000672	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.07e-05	0.000667	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPC5—multiple sclerosis	1.07e-05	0.000666	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.07e-05	0.000663	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.06e-05	0.000662	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—MAPK1—multiple sclerosis	1.06e-05	0.000659	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.05e-05	0.000655	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—MAPK1—multiple sclerosis	1.04e-05	0.000648	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—MAPK1—multiple sclerosis	1.03e-05	0.000644	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—MAPK1—multiple sclerosis	1.01e-05	0.000632	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.62e-06	0.000599	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.34e-06	0.000582	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.18e-06	0.000572	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.02e-06	0.000562	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.96e-06	0.000558	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—MAPK1—multiple sclerosis	8.87e-06	0.000553	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—RRM1—multiple sclerosis	8.86e-06	0.000552	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP24A1—multiple sclerosis	8.81e-06	0.000549	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP27B1—multiple sclerosis	8.81e-06	0.000549	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.8e-06	0.000548	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	8.14e-06	0.000507	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPC5—multiple sclerosis	8.06e-06	0.000502	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SRM—multiple sclerosis	7.7e-06	0.00048	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.69e-06	0.000479	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.14e-06	0.000445	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.06e-06	0.00044	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—BCHE—multiple sclerosis	7.02e-06	0.000437	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—RRM1—multiple sclerosis	6.67e-06	0.000416	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—BCHE—multiple sclerosis	6.44e-06	0.000401	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.16e-06	0.000384	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.14e-06	0.000383	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.02e-06	0.000375	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.74e-06	0.000357	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.43e-06	0.000338	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.43e-06	0.000338	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—BCHE—multiple sclerosis	5.09e-06	0.000317	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.96e-06	0.000309	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—APOE—multiple sclerosis	4.22e-06	0.000263	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.11e-06	0.000256	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APOE—multiple sclerosis	3.88e-06	0.000241	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.86e-06	0.00024	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—BCHE—multiple sclerosis	3.83e-06	0.000239	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—POMC—multiple sclerosis	3.63e-06	0.000226	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—POMC—multiple sclerosis	3.33e-06	0.000207	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALB—multiple sclerosis	3.31e-06	0.000206	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APOE—multiple sclerosis	3.06e-06	0.000191	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALB—multiple sclerosis	3.04e-06	0.000189	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—POMC—multiple sclerosis	2.63e-06	0.000164	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALB—multiple sclerosis	2.4e-06	0.000149	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.36e-06	0.000147	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APOE—multiple sclerosis	2.31e-06	0.000144	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—POMC—multiple sclerosis	1.98e-06	0.000123	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALB—multiple sclerosis	1.81e-06	0.000113	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APOE—multiple sclerosis	1.42e-06	8.85e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—POMC—multiple sclerosis	1.22e-06	7.6e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALB—multiple sclerosis	1.11e-06	6.93e-05	CbGpPWpGaD
